RecruitingPhase 3NCT07363720

A Trial of TAK-861 for the Treatment of Narcolepsy With Cataplexy

Studying Narcolepsy

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Takeda
Principal Investigator
Study Director
Takeda
Intervention
TAK-861(drug)
Enrollment
88 enrolled
Eligibility
16-70 years · All sexes
Timeline
20262026

Study locations (7)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07363720 on ClinicalTrials.gov

Other trials for Narcolepsy

Additional recruiting or active studies for the same condition.

See all trials for Narcolepsy

← Back to all trials